Metraipolis › archive › dc_3d69ee96e6f2
Cost-effectiveness of pramipexole augmentation for acute phase and maintenance therapy of treatment-resistant depression compared to placebo augmentation:… — Europe PMC PMID:41333541
- Source
- Europe PMC (en)
- Original
- https://europepmc.org/article/MED/41333541
- DOI
- 10.1016/j.lanepe.2025.101533
- License (as archived)
- solo-consultazione
- Archived
- 2026-11-08T12:12:26.705Z
- SHA-256 of the archived text
7ebca08e5f99c3275017c9196bc8f8851516c37d7af8a79f99cef9449f2ab41e- Stable URL of this page
https://metraipolis.com/documento/dc_3d69ee96e6f2
How to cite
Cost-effectiveness of pramipexole augmentation for acute phase and maintenance therapy of treatment-resistant depression compared to placebo augmentation:… — Europe PMC PMID:41333541 — Europe PMC (en), https://europepmc.org/article/MED/41333541 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_3d69ee96e6f2 (Metraipolis archive dc_3d69ee96e6f2, sha256 7ebca08e5f99c3275017c9196bc8f8851516c37d7af8a79f99cef9449f2ab41e)
BibTeX
@misc{dc3d69ee96e6f2,
title = {Cost-effectiveness of pramipexole augmentation for acute phase and maintenance therapy of treatment-resistant depression compared to placebo augmentation:… — Europe PMC PMID:41333541},
howpublished = {Europe PMC (en)},
url = {https://europepmc.org/article/MED/41333541},
note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_3d69ee96e6f2; sha256 7ebca08e5f99c3275017c9196bc8f8851516c37d7af8a79f99cef9449f2ab41e},
year = {2026}
}Archived text
The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/41333541. Agents can read the archived copy with the MCP tool read_document.